Navigation Links
Growing Interest in Regenerative Medicine to Drive the Mesenchymal Stem Cells Market, According to a Soon to Be Released Report by Global Industry Analysts, Inc.
Date:12/5/2013

San Jose, CA (PRWEB) December 05, 2013

Follow us on LinkedIn – GIA invites senior industry executives, domain experts, technologists and market strategists to participate in a comprehensive global research initiative studying the “Mesenchymal Stem Cells (MSCs)” markets. The study will examine key drivers and trends impacting the market such as increased investments in MSC research; advances in autologous MSCs; rise in the number of patent applications in the field of human tissue regeneration; growing prominence of oncology, orthopedics, inflammatory disorders, and cardiology as lucrative therapeutic application areas; and growing interest in the use of MSCs for providing personalized cell therapy for autoimmune diseases.

A rapidly growing area of stem cell research, Mesenchymal Stem Cells (MSCs) are defined as progenitor cells capable of producing multiple types of specialized cells in the body such as, osteoblasts, chondrocytes, adipocytes, myocytes, and neuronal cells. MSCs reside in bone marrow and other tissues such as umbilical cord, fat and muscle tissues. Ability of MSCs to repair tissue damage is resulting in increased interest in MSC based research in the field of tissue engineering and regenerative medicine. The last few years have witnessed significant increase in the number of clinical studies focused on MSC based bone and cartilage repair, heart and blood vessel repair. With cellular therapies now emerging as the new frontier of modern medical treatment, MSCs based regenerative approaches to treating neurological diseases is expected to bring in new opportunities for growth in the market. Breakthrough developments in delivery of MSCs through intracerebral or intrathecal injections remain critical for successful commercialization of MSC-based cellular therapies for neurodegenerative disorders. The market is also expected to benefit from increased use of MSCs in cell-based screening assays, such as, siRNA screening and biomolecule screening. In addition, cutting edge developments in genetically engineered MSCs as delivery vehicles for treatment will largely influence future market growth.

Other promising application areas include use of MSCs as immunomodulators in treating graft-versus-host (GVHD) disease, preventing transplant rejection, to enhance islet transplantation success in treatment of type I diabetes, and as anti-cancer agents in cancer treatment. MSC-based cancer therapies especially are expected to witness strong R&D interest, given the tumor-trophic migratory properties of MSCs. The study estimates Mesenchymal Stem Cells (MSCs) to be a multi-million dollar market worldwide, while more precise market-size and growth projections will be made available during the 2nd stage of report preparation, and data analysis.

The research and analyses will be released shortly in the form of a comprehensive research report. The report by design, will attempt to provide exhaustive analysis, data, trends, market share, market size, statistics, forecasts and competitive intelligence. The report is modeled to offer precise and unbiased, actionable market insights including in-depth segmentation of market sub-sectors, demand estimates and projections and analysis of trends in each of the sectors, identification of leading players, and the competitive structure, among others.

Developed for Drug Developers, Strategic Planners, Business Development Executives, Management Consultants, Investment Bankers, Consulting Firms, Marketing & Sales Executives, C-Level Decision Makers, Market Strategists and Technology Domain Experts, the report helps identify the biggest opportunities in this space and offers accurate latent demand forecasting that empowers quantitative decision making among existing market players and new entrants.

For more details about how you can participate, please click here.

About Global Industry Analysts, Inc.
Global Industry Analysts, Inc., (GIA) is a leading publisher of off-the-shelf market research. Founded in 1987, the company currently employs over 800 people worldwide. Annually, GIA publishes more than 1300 full-scale research reports and analyzes 40,000+ market and technology trends while monitoring more than 126,000 Companies worldwide. Serving over 9500 clients in 27 countries, GIA is recognized today, as one of the world's largest and reputed market research firms.

Follow us on LinkedIn

Global Industry Analysts, Inc.
Telephone: 408-528-9966
Fax: 408-528-9977
Email: press(at)StrategyR(dot)com
Web Site: http://www.StrategyR.com/

Read the full story at http://www.prweb.com/releases/mesenchymal_stem_cells/stem_cells_research/prweb11395229.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Wake Forest Baptist Medical Center Unveils Historic World-Class Biotech Research & Innovation Center in Downtown Winston-Salems Growing Piedmont Triad Research Park
2. How the alphabet of data processing is growing: Research team generates flying qubits
3. New Approach to Growing Waste to Value Industry in United States
4. BioSpace Spotlights the growing Midwest Life Science Community
5. Enterologics Highlights Growing News on Probiotics on the Web
6. Seahorse Bioscience Ranks No. 1600 on the Inc. 500
7. 5000 List of Fastest-Growing Private Companies in America for 2012 with Three-Year Sales Growth of 183%
8. AllCells, LLC Named to Inc. Magazines 500/5000 List of Fastest Growing Companies
9. Breast cancer cells growing in 3D-matrix revert to normal
10. Ramey & Browning Announces New Location and New Hire Firm Is Well Positioned to Address Growing Client Needs In 2013
11. Growing Job-Market Niche Inside The Economic Decline: A Wysebridge Review
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/5/2016)... , Feb. 5, 2016 ATCC, the ... poised to assist the medical and life science researchers ... Zika Virus infection.   CDC website . ... --> Zika virus is a single-stranded RNA virus ... the West Nile, Dengue and Chikungunya Viruses. Zika virus ...
(Date:2/4/2016)... ... February 04, 2016 , ... Morf Media Inc ... an interactive FDA compliance training course, Writing Effective SOPs ... accredited interactive course on Morf Playbook—now conveniently available on smartphones and PCs--provides step ...
(Date:2/4/2016)... Feb. 4, 2016 Beike Biotechnology, the ... institutions attended a ceremony in late 2015 to mark ... therapy in 2016. --> ... Platform for Personalized Cell Therapy" was hosted by the ... Center, both subsidiaries of Beike Biotechnology Co., Ltd. ...
(Date:2/4/2016)... Md. , Feb. 4, 2016  Spherix Incorporated ... to the fostering and monetization of intellectual property, today ... and Uniden in the Northern District of ... moving forward.  Inter Partes Re-examination ... U.S. Patent Office.  The IPR was initiated on only ...
Breaking Biology Technology:
(Date:2/2/2016)... , Feb. 2, 2016  Based on ... Frost & Sullivan recognizes US-based Intelligent Retinal Imaging ... & Sullivan Award for New Product Innovation. IRIS, ... North America , is poised ... rapidly growing diabetic retinopathy market. The IRIS technology ...
(Date:1/28/2016)... 28, 2016 Synaptics (NASDAQ: SYNA ), a leading ... second quarter ended December 31, 2015. --> ... fiscal 2016 increased 2 percent compared to the comparable quarter last ... fiscal 2016 was $35.0 million, or $0.93 per diluted share. ... for the first quarter of fiscal 2016 grew 9 percent over ...
(Date:1/22/2016)... 2016 http://www.researchandmarkets.com/research/4lmf2s/global_behavioral ... the  "Global Behavioral Biometric Market 2016-2020" ... http://www.researchandmarkets.com/research/4lmf2s/global_behavioral ) has announced the ... Market 2016-2020"  report to their offering. ... http://www.researchandmarkets.com/research/4lmf2s/global_behavioral ) has announced the addition ...
Breaking Biology News(10 mins):